Anna Christina Schaar

Anna Christina Schaar

Auto-generated profile, based on publicly available information

Anna Christina Schaar

Institute of Computational Biology, Helmholtz Center Munich, Germany.

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2023 in Nature Reviews Genetics
Verified
Journal Article
Closed access
PDF file
LHLukas Heumos
Lukas Heumos
ASAnna C. Schaar
Anna C. Schaar
CLChristopher Lance
Christopher Lance
ALAnastasia Litinetskaya
Anastasia Litinetskaya
FDFelix Drost
Felix Drost
FTFabian J. Theis
Fabian J. Theis

20 February 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
GPGiovanni Palla
Giovanni Palla
HSHannah Spitzer
Hannah Spitzer
MKMichal Klein
Michal Klein
DFDavid Fischer
David Fischer
ASAnna Christina Schaar
Anna Christina Schaar
FTFabian J. Theis
Fabian J. Theis
Spatial omics data are advancing the study of tissue organization and cellular communication at an unprecedented scale. Here, we present Squidpy, a Python framework that brings together tools from omics and image analysis to enable scalable description of spatial molecular data, such as transcriptome or multivariate proteins. Squidpy provides both infrastructure and numerous analysis methods that allow to efficiently store, manipulate and interactively visualize spatial omics data.

17 April 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
ASAnna Christina Schaar
Anna Christina Schaar
ATAlejandro Tejada-Lapuerta
Alejandro Tejada-Lapuerta
GPGiovanni Palla
Giovanni Palla
RGRobert Gutgesell
Robert Gutgesell
LHLennard Halle
Lennard Halle
FTFabian J. Theis
Fabian J. Theis
Tissue makeup relies fundamentally on the cellular microenvironment. Spatial single-cell genomics allows probing the underlying cellular interactions in an unbiased, scalable fashion. To learn a unified cell representation that accounts for local dependencies in the cellular microenvironment, we propose Nicheformer, a transformer-based foundation model that combines human and mouse dissociated single-cell and targeted spatial transcriptomics data. Pretrained on over 57 million dissociated and 53 million spatially resolved cells across 73 tissues on cellular reconstruction, the model is fine-tuned on spatial tasks for spatial omics data to decode spatially resolved cellular information. Nicheformer excels in linear-probing and fine-tuning scenarios for a novel set of downstream tasks, in particular spatial composition prediction and spatial label prediction. We further show that existing foundation models trained on dissociated single-cell data alone are not capable of recapitulating the spatial complexity of cells in their microenvironments, indicating that multiscale models are required to understand complex local dependencies at scale. Nicheformer enables the prediction of the spatial context of dissociated cells, allowing the transfer of rich spatial information to scRNA-seq datasets. Overall, Nicheformer sets the stage for the next generation of machine-learning models in spatial single-cell analysis.

12 July 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
DFDavid S. Fischer
David S. Fischer
ASAnna C. Schaar
Anna C. Schaar
FTFabian J. Theis
Fabian J. Theis
Tissue niches are sources of cellular variation and key to understanding both single-cell and tissue phenotypes. The interaction of a cell with its niche can be described through cell communication events. These events cannot be directly observed in molecular profiling assays of single cells and have to be inferred. However, computational models of cell communication and variance attribution defined on data from dissociated tissues suffer from multiple limitations with respect to their ability to define and to identify communication events. We address these limitations using spatial molecular profiling data with node-centric expression modeling (NCEM), a computational method based on graph neural networks which reconciles variance attribution and communication modeling in a single model of tissue niches. We use these models in varying complexity across spatial assays, such as immunohistochemistry and MERFISH, and biological systems to demonstrate that the statistical cell–cell dependencies discovered by NCEM are plausible signatures of known molecular processes underlying cell communication. We identify principles of tissue organisation as cell communication events across multiple datasets using interpretation mechanisms. In the primary motor cortex, we found gene expression variation that is due to niche composition variation across cortical depth. Using the same approach, we also identified niche-dependent cell state variation in CD8 T cells from inflamed colon and colorectal cancer. Finally, we show that NCEMs can be extended to mixed models of explicit cell communication events and latent intrinsic sources of variation in conditional variational autoencoders to yield holistic models of cellular variation in spatial molecular profiling data. Altogether, this graphical model of cellular niches is a step towards understanding emergent tissue phenotypes.

1 July 2025 in Bioinformatics
Verified
Journal Article
Open access
SOSarah Ouologuem
Sarah Ouologuem
LMLaura D Martens
Laura D Martens
ASAnna C Schaar
Anna C Schaar
MSMaiia Shulman
Maiia Shulman
JGJulien Gagneur
Julien Gagneur
FTFabian J Theis
Fabian J Theis
Motivation: Spatially resolved chromatin accessibility profiling offers the potential to investigate gene regulatory processes within the spatial context of tissues. However, current methods typically work at spot resolution, aggregating measurements from multiple cells, thereby obscuring cell-type-specific spatial patterns of accessibility. Spot deconvolution methods have been developed and extensively benchmarked for spatial transcriptomics, yet no dedicated methods exist for spatial chromatin accessibility, and it is unclear if RNA-based approaches are applicable to that modality. Results: Here, we demonstrate that these RNA-based approaches can be applied to spot-based chromatin accessibility data by a systematic evaluation of five top-performing spatial transcriptomics deconvolution methods. To assess performance, we developed a simulation framework that generates both transcriptomic and accessibility spot data from dissociated single-cell and targeted multiomic datasets, enabling direct comparisons across both data modalities. Our results show that Cell2location and RCTD, in contrast to other methods, exhibit robust performance on spatial chromatin accessibility data, achieving accuracy comparable to RNA-based deconvolution. Generally, we observed that RNA-based deconvolution exhibited slightly better performance compared to chromatin accessibility-based deconvolution, especially for resolving rare cell types, indicating room for future development of specialized methods. In conclusion, our findings demonstrate that existing deconvolution methods can be readily applied to chromatin accessibility-based spatial data. Our work provides a simulation framework and establishes a performance baseline to guide the development and evaluation of methods optimized for spatial epigenomics. Availability and implementation: All methods, simulation frameworks, peak selection strategies, analysis notebooks and scripts are available at https://github.com/theislab/deconvATAC.

13 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
QBQuentin Bayard
Quentin Bayard
ZMZelda Mariet
Zelda Mariet
ASAnna Schaar
Anna Schaar
EREkaterina Rozhavskaya
Ekaterina Rozhavskaya
MMMaria Mahfoud
Maria Mahfoud
AEAlmudena Espin-Perez
Almudena Espin-Perez
Emerging high-throughput sequencing technologies promise lower costs and higher scalability, yet their performance on archival clinical samples remains poorly characterized. Here, we benchmarked Ultima Genomics UG100 against Illumina Novaseq platforms across single-nuclei RNA-seq (snRNA-seq), whole-transcriptome (WTS), whole-exome (WES), and whole-genome sequencing (WGS) using FFPE tissues from oncologic and immune-mediated diseases. Across matched samples, we systematically assessed data quality, coverage profiles, error spectra, variant concordance and transcriptomic reproducibility. UG100 produced highly comparable results to Illumina, capturing key oncogenic and immune-related transcripts, accurately resolving cellular composition in snRNA-seq, and maintaining sensitivity for lowly expressed genes, despite characteristic insertion-biased indels and modest differences in multi-mapping reads. Discrepancies were subtle, largely limited to pseudogene and non-coding transcripts, and did not affect pathway-level conclusions. Ultima UG100 platform prioritized high precision and reduced low-frequency artifacts, offering a cleaner but more conservative variant-calling profile compared to the more sensitive, yet noisier, Illumina/DRAGEN workflow. This multimodal, clinically oriented assessment provides the first comprehensive evaluation of UG100, demonstrating its translational utility in population-scale genomics, and highlighting the potential for emerging sequencing technologies to lower the cost of biomedical research and clinical diagnostics.